8DM Esterified Impurity ZH1 (Separation and Purification)

CAS Number: N/A

Product Code: REF-QT03424

Molecular formula: C24H32O5

Molecular weight: 400.52

Purity: 95.76%

Product nature: Customized for customers

Appearance characteristics: N/A

Storage conditions:- 20℃

Chemical name: 2- ((8S, 10S, 13S, 14S, 16R, 17R) -17-hydroxy-10,13,16-trimethyl-3-oxo-2,3,6,7,8,10,12,13,14,15,16,17-dodecahydroxy-1H-cyclopenta [a] phenylhren-17-yl) -2-oxoethyl acetate

 Hot Tags:8DM Esterified Impurity ZH1 (Separation and Purification), China, suppliers, manufacturers, factory, customized, price, pricelist, in stock。

Synthesis of 8DM Esterified Impurity ZH1 (Separation and Purification)

8DM Esterified Impurity ZH1 (Separation and Purification) Reference Standards, 

Complex Impurity Of 8DM Esterified Impurity ZH1 (Separation and Purification)

Chemical Standards of 8DM Esterified Impurity ZH1 (Separation and Purification)

Characterization Of Unknown Impurities of 8DM Esterified Impurity ZH1 (Separation and Purification)

Structure Profiling of 8DM Esterified Impurity ZH1 (Separation and Purification)

Identification of 8DM Esterified Impurity ZH1 (Separation and Purification)

Isolation & Purification of Impurity of 8DM Esterified Impurity ZH1 (Separation and Purification)

Difficult  of 8DM Esterified Impurity ZH1 (Separation and Purification)

Instability  of 8DM Esterified Impurity ZH1 (Separation and Purification)

Low-assay of 8DM Esterified Impurity ZH1 (Separation and Purification)

Complex Impurity Of Chemical Standards of 8DM Esterified Impurity ZH1 (Separation and Purification)

    TOSUN PHARM was established in 1999. In China, it is a collection of drugs, APIs, reference listed drugs, impurities, excipients, intermediates import and export, import registration services, generic drug research and development services, innovative drugs and high-end FDF technology transfer, A group company integrating marketing, academic promotion and cooperative production. With a global procurement, R&D and marketing network, it can quickly meet the needs of product R&D, production and market sales of Chinese and global pharmaceutical companies.